HIV DART and Emerging Viruses 2016

Slideset

HIV

(Abstract) Predicting Antiviral Drug Toxicity Using Contractility Analysis Of Human IPSC Derived Cardiomyocytes | Brian D. Herman

Slideset

HIV

State of the Art Lecture: What Do We Really Know About Dengue Viruses | Oscar Perng, PhD

Slideset

HIV

(Abstract) In Silico Approaches Towards Broadly Active Flavivirus Protease Inhibitors | Bryan D. Cox

Slideset

HIV

HIV-1 Macrophage Reservoirs: Lessons from Host Macrophage Specific Restriction Factor, SAMHD1 | Baek Kim, PhD

Slideset

HIV

David Barry DART Achievement Award Lecture: The Discovery of SIV and Development of Monkey Models for the Study of HIV/ AIDS | Ronald Desrosiers, PhD

Slideset

HIV

(Abstract) Differential responses of memory CD4+ T cell subsets to HIV latency reversing agents | D. Kulpa

Slideset

HIV

(Abstract) HIV-1 dynamics under integrase inhibitor therapy suggests a subset of cells with slow integration | R.M. Ribeiro

Slideset

HIV

Impact of Jak Inhibitors on HIV Reservoir Maintenance, Lifespan and Expansion in Primary T Cells and Macrophages | Christina Gavegnano, PhD

Slideset

HIV

Current Clinical Therapies for HIV Remission | David Margolis, MD

Slideset

HIV

(Abstract) Anti–HIV drug candidate abx464 prevents intestinal inflammation by producing IL22 in activated macrophages | J. Tazi

Slideset

HIV

Gertrude Elion Distinguished Lecturer Award Lecture Stories on Scientific Discoveries that Transformed HIV into a Manageable Disease | Mark Wainberg, MD

Slideset

HIV

(Abstract) Development of a protease inhibitor-based single-tablet complete HIV-1 regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (DCFTAF) | B. Baugh

Slideset

HIV

(Abstract) Antiviral Activity of tenofovir alafenamide against HIV-1 with thymidine analog mutation(s) and M184V | C. Callebaut

Slideset

HIV

Management of Neurocognitive Impairment of Aging Populations Living with HIV | Scott Letendre, MD

Slideset

HIV

HIV DART and Emerging Viruses 2016

(Abstract) Predicting Antiviral Drug Toxicity Using Contractility Analysis Of Human IPSC Derived Cardiomyocytes | Brian D. Herman

State of the Art Lecture: What Do We Really Know About Dengue Viruses | Oscar Perng, PhD

Global Burden and Novel Treatment of Noroviruses | Ladislau Kovari, PhD

Zika Neuropathies Beyond Microcephaly | Maurício Lacerda Nogueira, MD, PhD

HIV Knowledge and Hope in Africa | Carol A. Harris, MD

Rapid Zika Detection for Resource-Limited Regions | Mark Sharkey, PhD

(Abstract) In Silico Approaches Towards Broadly Active Flavivirus Protease Inhibitors | Bryan D. Cox

HIV-1 Macrophage Reservoirs: Lessons from Host Macrophage Specific Restriction Factor, SAMHD1 | Baek Kim, PhD

David Barry DART Achievement Award Lecture: The Discovery of SIV and Development of Monkey Models for the Study of HIV/ AIDS | Ronald Desrosiers, PhD

(Abstract) Differential responses of memory CD4+ T cell subsets to HIV latency reversing agents | D. Kulpa

(Abstract) HIV-1 dynamics under integrase inhibitor therapy suggests a subset of cells with slow integration | R.M. Ribeiro

Impact of Jak Inhibitors on HIV Reservoir Maintenance, Lifespan and Expansion in Primary T Cells and Macrophages | Christina Gavegnano, PhD

Current Clinical Therapies for HIV Remission | David Margolis, MD

(Abstract) Anti–HIV drug candidate abx464 prevents intestinal inflammation by producing IL22 in activated macrophages | J. Tazi

Gertrude Elion Distinguished Lecturer Award Lecture Stories on Scientific Discoveries that Transformed HIV into a Manageable Disease | Mark Wainberg, MD

(Abstract) Development of a protease inhibitor-based single-tablet complete HIV-1 regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (DCFTAF) | B. Baugh

(Abstract) Antiviral Activity of tenofovir alafenamide against HIV-1 with thymidine analog mutation(s) and M184V | C. Callebaut

Management of Neurocognitive Impairment of Aging Populations Living with HIV | Scott Letendre, MD

Collateral Damage with Antiviral Therapy | David Thomas, MD, MPH